{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T21:16:55Z","timestamp":1777238215998,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaut.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:31:00Z","timestamp":1540287060000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Autoimmune sclerosing cholangitis: Evidence and open questions"],"prefix":"10.1016","volume":"95","author":[{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cld.2015.08.008","article-title":"Sclerosing cholangitis in children and adolescents","volume":"20","author":"Mieli-Vergani","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.008_bib2","article-title":"Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","author":"Mieli-Vergani","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.29208","article-title":"The riddle of juvenile sclerosing cholangitis","volume":"66","author":"Mieli-Vergani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jaut.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3476(80)80690-1","article-title":"Sclerosing cholangitis in childhood","volume":"96","author":"Werlin","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/000992288202100101","article-title":"Sclerosing cholangitis associated with inflammatory bowel disease","volume":"21","author":"Freese","year":"1982","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.jaut.2018.10.008_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(82)90134-2","article-title":"A case of primary sclerosing cholangitis in childhood","volume":"82","author":"Spivak","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"el-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib11","unstructured":"Minuk: Autoimmune Chronic Active Hepatitis (Lupoid\u2026 - Google Scholar, (n.d.). https:\/\/scholar.google.com\/scholar_lookup?title=Autoimmune%20chronic%20active%20hepatitis%20(lupoid%20hepatitis)%20and%20primary%20sclerosing%20cholangitis%20in%20two%20young%20adult%20females&author=Minak%2CG&author=Sutherland%2CLR&author=Pappas%2CC&journal=Can%20J%20Gastroenterol&volume=2&pages=22-27&publication_year=1988 (accessed July 15, 2018)."},{"key":"10.1016\/j.jaut.2018.10.008_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/BF01296509","article-title":"Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis","volume":"37","author":"Rabinovitz","year":"1992","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2018.10.008_bib13","unstructured":"Autoimmune Chronic Active Hepatitis Evolving to Primary Sclerosing Cholangitis - Evidence for a Common Pathogenesis - UQ eSpace, (n.d.). https:\/\/espace.library.uq.edu.au\/view\/UQ:411304 (accessed July 15, 2018)."},{"key":"10.1016\/j.jaut.2018.10.008_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-1007301","article-title":"A 39 year old man with chronic hepatitis","volume":"14","author":"Lawrence","year":"1994","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.008_bib15","doi-asserted-by":"crossref","first-page":"129A","DOI":"10.1016\/0270-9139(95)94240-8","article-title":"Overlap between type 1 autoimmune hepatitis and primary sclerosing cholangitis","volume":"22","author":"Roberts","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib16","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.1840220537","article-title":"A 28-year-old woman with a combined hepatitic\/cholestatic syndrome","volume":"22","author":"Wurbs","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Zum B\u00fcschenfelde, Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the liver, EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American association for the study of liver diseases, diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejrad.2012.08.009","article-title":"Paediatric MRCP: 10 year experience with 195 patients","volume":"82","author":"Philpott","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.jaut.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00247-008-0918-6","article-title":"Primary sclerosing cholangitis in children: utility of magnetic resonance cholangiopancreatography","volume":"38","author":"Chavhan","year":"2008","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.jaut.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00247-001-0617-z","article-title":"Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children","volume":"32","author":"Ferrara","year":"2002","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.jaut.2018.10.008_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinre.2013.05.014","article-title":"Diagnosis of sclerosing cholangitis in children: blinded, comparative study of magnetic resonance versus endoscopic cholangiography","volume":"37","author":"Rossi","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-2008-1077509","article-title":"Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Weber","year":"2008","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaut.2018.10.008_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00431-018-3181-3","article-title":"Bile duct paucity in childhood-spectrum, profile, and outcome","volume":"177","author":"Meena","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.008_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.510230435","article-title":"Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis","volume":"23","author":"Deleuze","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib28","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jgh.13774","article-title":"Variations in primary sclerosing cholangitis across the age spectrum","volume":"32","author":"Eaton","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e3283388f5b","article-title":"Unique features of primary sclerosing cholangitis in children","volume":"26","author":"Mieli-Vergani","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jhep.2016.07.017","article-title":"University of Washington Center for Mendelian Genomics, L. Bull, R.J. Thompson, Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis","volume":"65","author":"Grammatikopoulos","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib33","article-title":"Genetic determinants of cholangiopathies: molecular and systems genetics","author":"Reichert","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2018.10.008_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24964","article-title":"Next generation sequencing in pediatric hepatology and liver transplantation","volume":"24","author":"Nicastro","year":"2018","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jaut.2018.10.008_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","volume":"64","author":"Fawaz","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib37","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"el-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib38","article-title":"Outcome and survival in childhood onset autoimmune sclerosing cholangitis and autoimmune hepatitis; A 13 years follow-up study","volume":"46","author":"Scalori","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib40","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.10.008_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(02)80564-5","article-title":"Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis","volume":"36","author":"Underhill","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/15513815.2014.898721","article-title":"Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents","volume":"33","author":"Rojas","year":"2014","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.jaut.2018.10.008_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(94)70253-5","article-title":"Sclerosing cholangitis in children","volume":"124","author":"Debray","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2018.10.008_bib44","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"International autoimmune hepatitis group, liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0000000000001125","article-title":"Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome","volume":"63","author":"Rodrigues","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1478-3231.1999.tb00040.x","article-title":"Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults","volume":"19","author":"Floreani","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.jaut.2018.10.008_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10024-005-0020-0","article-title":"Primary sclerosing cholangitis in children: a histologic follow-up study","volume":"8","author":"Batres","year":"2005","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.jaut.2018.10.008_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A retrospective single-center review of primary sclerosing cholangitis in children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib51","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International autoimmune hepatitis group, simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib55","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/2050640615616012","article-title":"Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis","volume":"4","author":"Tenca","year":"2016","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.jaut.2018.10.008_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001368","article-title":"The natural history of primary sclerosing cholangitis in children: a large single-center longitudinal cohort study","volume":"63","author":"Valentino","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5223\/pghn.2015.18.4.268","article-title":"Primary sclerosing cholangitis with inflammatory bowel disease in Korean children","volume":"18","author":"Yoon","year":"2015","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib58","first-page":"412","article-title":"Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis","volume":"15","author":"Smolka","year":"2016","journal-title":"HBPD Int."},{"key":"10.1016\/j.jaut.2018.10.008_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/s0004-2803.201700000-50","article-title":"Primary sclerosing cholangitis in children and adolescents","volume":"54","author":"Fagundes","year":"2017","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib60","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib61","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib62","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Beretta-Piccoli","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.008_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-012-9801-1","article-title":"Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Abarbanel","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.10.008_bib65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","article-title":"Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity","volume":"60","author":"Vrieze","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib67","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMcpc030004","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2003. A 14-year-old boy with ulcerative colitis, primary sclerosing cholangitis, and partial duodenal obstruction","volume":"348","author":"Ross","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.008_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"European association for the study of the liver, EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib69","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jaut.2018.10.008_bib70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jaut.2018.10.008_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","article-title":"Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"66","author":"Henriksen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MPG.0000000000000755","article-title":"Biliary atresia: clinical lessons learned","volume":"61","author":"Feldman","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.008_bib73","article-title":"Assessment of liver disease in cystic fibrosis","author":"Davison","year":"2018","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.jaut.2018.10.008_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4067\/S0034-98872003000100003","article-title":"Digestive pathology in children infected with the human immunodeficiency virus (HIV), in Santiago de Chile","volume":"131","author":"Tassara","year":"2003","journal-title":"Rev. Med. Chile"},{"key":"10.1016\/j.jaut.2018.10.008_bib75","first-page":"270","article-title":"Retroperitoneal fibrosis in children","volume":"72","author":"Chv\u00e1tal","year":"1993","journal-title":"Rozhl Chir."},{"key":"10.1016\/j.jaut.2018.10.008_bib76","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840170510","article-title":"Biliary abnormalities associated with extrahepatic portal venous obstruction","volume":"17","author":"Khuroo","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jaut.2018.10.008_bib78","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1665-2681(19)30764-1","article-title":"Secondary sclerosing cholangitis following major burn","volume":"14","author":"Ben-Ari","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.008_bib79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.008_bib80","first-page":"114","article-title":"Primary sclerosing cholangitis associated with immunodeficiency","volume":"137","author":"Naveh","year":"1983","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.jaut.2018.10.008_bib81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0016-5085(86)90584-6","article-title":"Primary sclerosing cholangitis associated with hyperimmunoglobulin M immunodeficiency (dysgammaglobulinemia)","volume":"91","author":"DiPalma","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.008_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0079-3","article-title":"IgG4-related disease: a systematic review of this unrecognized disease in pediatrics","volume":"14","author":"Karim","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:20:29Z","timestamp":1760257229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118305390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":82,"alternative-id":["S0896841118305390"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune sclerosing cholangitis: Evidence and open questions","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}